CAITLIN SMITH: Open Payments
NPI 1326445834 · DENVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$793 in 42 payments from 15 companies in 2025. Trend: 2023 $465 · 2024 $987 · 2025 $793
Food & beverage: $793
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 12 | $227 |
| Merck Sharp & Dohme LLC | 7 | $127 |
| AstraZeneca Pharmaceuticals LP | 4 | $78 |
| GlaxoSmithKline, LLC. | 3 | $65 |
| Novartis Pharmaceuticals Corporation | 3 | $51 |
| Philips North America LLC | 2 | $38 |
| Agios Pharmaceuticals, Inc. | 2 | $36 |
| Eisai Inc. | 2 | $34 |
| Caris MPI, Inc. | 1 | $26 |
| Genmab U.S., Inc. | 1 | $20 |
Products named: Enhertu, KEYTRUDA, KISQALI, JEMPERLI, PYRUKYND, Lenvima, LYNPARZA, MI CANCER SEEK.
Industry payments across NJ — which companies pay providers there.
